Indicus Pharma's Metformin Hydrochloride ANDA079148 Receives AP Status
Indicus Pharma's ANDA for Metformin Hydrochloride has been granted Abbreviated Approval (AP) status by the FDA.
Company
Pharmaceutical intelligence for Indicus Pharma with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.